Bicara therapeutics to present at the stifel 2024 healthcare conference

Boston, nov. 11, 2024 (globe newswire) -- bicara therapeutics inc. (nasdaq: bcax), a clinical-stage biopharmaceutical company committed to bringing transformative bifunctional therapies for patients with solid tumors, today announced that claire mazumdar, phd, mba, chief executive officer of bicara therapeutics, will present at the stifel 2024 healthcare conference in new york, ny on tuesday, november 19, 2024 at 9:10 a.m. et.
BCAX Ratings Summary
BCAX Quant Ranking